UnknownPhase 3NCT04844905

Adjunctive Ivermectin Mass Drug Administration for Malaria Control

Studying Ankylostomiasis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
London School of Hygiene and Tropical Medicine
Principal Investigator
Anna R Last, MBChB PhD
London School of Hygiene and Tropical Medicine
Intervention
Ivermectin(drug)
Enrollment
24000 enrolled
Eligibility
All sexes
Timeline
20212023

Study locations (1)

Collaborators

Medical Research Council Unit, The Gambia · Ministerio de Saude Publica, Guinee-Bissau · Bandim Health Project · Instituto Nacional de Estudos e Pesquisas, Guinee-Bissau

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04844905 on ClinicalTrials.gov

Other trials for Ankylostomiasis

Additional recruiting or active studies for the same condition.

See all trials for Ankylostomiasis

← Back to all trials